Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS)

Rheumatology (Oxford). 2007 Dec;46(12):1865-6. doi: 10.1093/rheumatology/kem231. Epub 2007 Oct 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Aza Compounds / administration & dosage
  • Chronic Disease
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Etanercept
  • Familial Mediterranean Fever / diagnosis*
  • Familial Mediterranean Fever / drug therapy*
  • Female
  • Fluoroquinolones
  • Follow-Up Studies
  • Humans
  • Immunoglobulin G / administration & dosage*
  • Male
  • Middle Aged
  • Moxifloxacin
  • Prospective Studies
  • Quinolines / administration & dosage
  • Receptors, Tumor Necrosis Factor / administration & dosage*
  • Receptors, Tumor Necrosis Factor, Type I / adverse effects*
  • Receptors, Tumor Necrosis Factor, Type I / metabolism*
  • Risk Assessment
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Aza Compounds
  • Fluoroquinolones
  • Immunoglobulin G
  • Quinolines
  • Receptors, Tumor Necrosis Factor
  • Receptors, Tumor Necrosis Factor, Type I
  • Adalimumab
  • Etanercept
  • Moxifloxacin